157 related articles for article (PubMed ID: 25564163)
21. Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma.
Uchikado Y; Natsugoe S; Okumura H; Setoyama T; Matsumoto M; Ishigami S; Aikou T
Clin Cancer Res; 2005 Feb; 11(3):1174-80. PubMed ID: 15709186
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).
Inada S; Koto T; Futami K; Arima S; Iwashita A
Surg Today; 1999; 29(6):493-503. PubMed ID: 10385363
[TBL] [Abstract][Full Text] [Related]
23. E-cadherin and alpha-catenin expression in human esophageal cancer.
Kadowaki T; Shiozaki H; Inoue M; Tamura S; Oka H; Doki Y; Iihara K; Matsui S; Iwazawa T; Nagafuchi A
Cancer Res; 1994 Jan; 54(1):291-6. PubMed ID: 8261454
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.
Ma W; Wang K; Yang S; Wang J; Tan B; Bai B; Wang N; Jia Y; Jia M; Cheng Y
Int J Clin Exp Pathol; 2014; 7(5):2361-71. PubMed ID: 24966946
[TBL] [Abstract][Full Text] [Related]
25. Novel monoclonal antibodies detect Smad-interacting protein 1 (SIP1) in the cytoplasm of human cells from multiple tumor tissue arrays.
Oztas E; Avci ME; Ozcan A; Sayan AE; Tulchinsky E; Yagci T
Exp Mol Pathol; 2010 Oct; 89(2):182-9. PubMed ID: 20515682
[TBL] [Abstract][Full Text] [Related]
26. Loss of PAR-3 protein expression is associated with invasion, lymph node metastasis, and poor survival in esophageal squamous cell carcinoma.
Kitaichi T; Yasui K; Gen Y; Dohi O; Iwai N; Tomie A; Yamada N; Terasaki K; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Naito Y; Zen Y; Itoh Y
Hum Pathol; 2017 Apr; 62():134-140. PubMed ID: 28188749
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.
Rosivatz E; Becker I; Specht K; Fricke E; Luber B; Busch R; Höfler H; Becker KF
Am J Pathol; 2002 Nov; 161(5):1881-91. PubMed ID: 12414534
[TBL] [Abstract][Full Text] [Related]
28. Characterisation of Prognosis and Invasion of Cutaneous Squamous Cell Carcinoma by Podoplanin and E-Cadherin Expression.
Hesse K; Satzger I; Schacht V; Köther B; Hillen U; Klode J; Schaper K; Gutzmer R
Dermatology; 2016; 232(5):558-565. PubMed ID: 27875814
[TBL] [Abstract][Full Text] [Related]
29. Tumor cell dissociation score highly correlates with lymph node metastasis in superficial esophageal carcinoma.
Chibana Y; Fujii S; Ichikawa K; Fujita M; Ono Y; Tomita S; Imura J; Kawamata H; Terano A; Fujimori T
J Gastroenterol Hepatol; 2005 Sep; 20(9):1371-8. PubMed ID: 16105123
[TBL] [Abstract][Full Text] [Related]
30. Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakamoto A; Owaki T; Aikou T
J Exp Clin Cancer Res; 2009 Dec; 28(1):158. PubMed ID: 20025748
[TBL] [Abstract][Full Text] [Related]
31. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray.
Peng H; Zhong XY; Liu KP; Li SM
Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414
[TBL] [Abstract][Full Text] [Related]
32. Analysis of a cytoskeleton-associated kinase PEAK1 and E-cadherin in gastric cancer.
Guo Q; Qin W; Li B; Yang H; Guan J; Liu Z; Li S
Pathol Res Pract; 2014 Dec; 210(12):793-8. PubMed ID: 25445115
[TBL] [Abstract][Full Text] [Related]
33. Epithelial-mesenchymal Transition (EMT) is Correlated with Patient's Prognosis of Lung Squamous Cell Carcinoma.
Aruga N; Kijima H; Masuda R; Onozawa H; Yoshizawa T; Tanaka M; Inokuchi S; Iwazaki M
Tokai J Exp Clin Med; 2018 Apr; 43(1):5-13. PubMed ID: 29637533
[TBL] [Abstract][Full Text] [Related]
34. Epithelial-to-mesenchymal transition in human esophageal cancer associates with tumor progression and patient's survival.
Liu J; Chen L; Deng H; Xu B; Li M; Zheng X; Wu C; Jiang J
Int J Clin Exp Pathol; 2014; 7(10):6943-9. PubMed ID: 25400779
[TBL] [Abstract][Full Text] [Related]
35. Decreased expression of E-cadherin and Yamamoto-Kohama's mode of invasion highly correlates with lymph node metastasis in esophageal squamous cell carcinoma.
Kaihara T; Kusaka T; Kawamata H; Oda Y; Fujii S; Morita K; Imura J; Fujimori T
Pathobiology; 2001; 69(3):172-8. PubMed ID: 11872963
[TBL] [Abstract][Full Text] [Related]
36. [Significance and expression of vascular endothelial growth factor-C (VEGF-C) in esophageal squamous carcinoma and glioma].
Pang XH; Tian H; Liu ZY; Li SM; Liu ST; Tian GP
Ai Zheng; 2003 Nov; 22(11):1166-9. PubMed ID: 14613645
[TBL] [Abstract][Full Text] [Related]
37. SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma.
Cui XB; Shen YY; Jin TT; Li S; Li TT; Zhang SM; Peng H; Liu CX; Li SG; Yang L; Li N; Hu JM; Jiang JF; Li M; Liang WH; Li Y; Wei YT; Sun ZZ; Wu CY; Chen YZ; Li F
J Transl Med; 2015 Oct; 13():321. PubMed ID: 26444413
[TBL] [Abstract][Full Text] [Related]
38. Expression of RKIP, E-cadherin and NF-kB p65 in esophageal squamous cell carcinoma and their correlations.
Ping FM; Liu GJ; Liu ZJ; Li HB; Zhai JW; Li SX; Liu YM; Li BW; Wei H
Int J Clin Exp Pathol; 2015; 8(9):10164-70. PubMed ID: 26617724
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
[TBL] [Abstract][Full Text] [Related]
40. Independent histological risk factors for lymph node metastasis of superficial esophageal squamous cell carcinoma; implication of claudin-5 immunohistochemistry for expanding the indications of endoscopic resection.
Chiba T; Kawachi H; Kawano T; Kumagai J; Kitagaki K; Sekine M; Uchida K; Kobayashi M; Sugihara K; Eishi Y
Dis Esophagus; 2010 Jul; 23(5):398-407. PubMed ID: 19903192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
